Loading…
Hepatocyte growth factor reverses the TGF-β-induced growth inhibition of CCL-64 cells: A novel bioassay for HGF and implications for the TGF-β bioassay
The influence of human hepatocyte growth factor (HGF) on the transforming growth factor β (TGF-β) bioassay CCL-64 was examined. HGF induced proliferation of the CCL-64 cells and potently counteracted TGF-β-induced growth inhibition. HGF was not inactivated by transient acidification to pH 2, a commo...
Saved in:
Published in: | Journal of immunological methods 1996-01, Vol.189 (1), p.59-64 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The influence of human hepatocyte growth factor (HGF) on the transforming growth factor β (TGF-β) bioassay CCL-64 was examined. HGF induced proliferation of the CCL-64 cells and potently counteracted TGF-β-induced growth inhibition. HGF was not inactivated by transient acidification to pH 2, a commonly used procedure to activate latent TGF-β. HGF was a stronger mitogen for the mink lung cells than epidermal growth factor (EGF), a known stimulator of CCL-64 cell growth. Costimulation of the cells by these two cytokines resulted in an additive effect on proliferation. In complex biological fluids containing large amounts of HGF, the TGF-β concentration can be underestimated when determined by the CCL-64 assay. When a fixed amount of TGF-β is added, the CCL-64 cells can be used as a reliable bioassay for HGF with a sensitivity of about 1 ng/ml. |
---|---|
ISSN: | 0022-1759 1872-7905 |
DOI: | 10.1016/0022-1759(95)00228-6 |